[1]
|
Yuki, K., Fujiogi, M. and Koutsogiannaki, S. (2020) COVID-19 Pathophysiology: A Review. Clinical Immunology, 215, Article ID: 108427. https://doi.org/10.1016/j.clim.2020.108427
|
[2]
|
Araf, Y., Faruqui, N.A., Anwar, S., et al. (2021) SARS-CoV-2: A New Dimension to Our Understanding of Coronaviruses. International Microbiology, 24, 19-24. https://doi.org/10.1007/s10123-020-00152-y
|
[3]
|
Li, S.R., Tang, Z.J., Li, Z.H., et al. (2020) Searching Therapeutic Strategy of New Coronavirus Pneumonia from Angiotensin-Converting Enzyme 2: The Target of COVID-19 and SARS-CoV. European Journal of Clinical Microbiology & Infectious Diseases, 39, 1021-1026. https://doi.org/10.1007/s10096-020-03883-y
|
[4]
|
Ciotti, M., Ciccozzi, M., Terrinoni, A., et al. (2020) The COVID-19 Pandemic. Critical Reviews in Clinical Laboratory Sciences, 57, 365-388. https://doi.org/10.1080/10408363.2020.1783198
|
[5]
|
Xu, L., Liu, J., Lu, M., Yang, D. and Zheng, X. (2020) Liver Injury during Highly Pathogenic Human Coronavirus infections. Liver International, 40, 998-1004. https://doi.org/10.1111/liv.14435
|
[6]
|
Chai, X., Hu, L., Zhang, Y., et al. (2020) Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage after 2019-nCoV Infection. BioRxiv. https://doi.org/10.1101/2020.02.03.931766
|
[7]
|
Lei, F., Liu, Y.M., Zhou, F., et al. (2020) Longitudinal Associa-tion between Markers of Liver Injury and Mortality in COVID‐19 in China. Hepatology, 72, 389-398. https://doi.org/10.1002/hep.31301
|
[8]
|
Wang, Y., Liu, S., Liu, H., et al. (2020) SARS-CoV-2 Infection of the Liv-er Directly Contributes to Hepatic Impairment in Patients with COVID-19. Journal of Hepatology, 73, 807-816. https://doi.org/10.1016/j.jhep.2020.05.002
|
[9]
|
Fan, Z., Chen, L., Li, J., et al. (2020) Clinical Features of COVID-19-Related Liver Functional Abnormality. Clinical Gastroenterology and Hepatology, 18, 1561-1566. https://doi.org/10.1016/j.cgh.2020.04.002
|
[10]
|
Feng, G., Zheng, K.I., Yan, Q.Q., et al. (2020) COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. Journal of Clinical and Translational Hepa-tology, 8, 18-24.
https://doi.org/10.14218/JCTH.2020.00018
|
[11]
|
Gao, R.Y., Wang, M., Liu, Q., et al. (2020) Hypoxia‐Inducible Factor‐2α Reprograms Liver Macrophages to Protect Against Acute Liver Injury through the Production of Interleukin‐6. Hepatology, 71, 2105-2117.
https://doi.org/10.1002/hep.30954
|
[12]
|
Cai, Q., Huang, D., Yu, H., et al. (2020) COVID-19: Abnormal Liver Function Tests. Journal of Hepatology, 73, 566- 574. https://doi.org/10.1016/j.jhep.2020.04.006
|
[13]
|
Ali, N. (2020) Relationship between COVID-19 Infection and Liver Injury: A Review of Recent Data. Frontiers in Medicine, 7, Article No. 458. https://doi.org/10.3389/fmed.2020.00458
|
[14]
|
李晓骄阳, 李雅静, 葛俊德, 吴恺懌, 孙蓉. 注重新型冠状病毒肺炎(COVID-19)治疗中药物性肝损伤的预警与保护[J]. 中草药, 2020, 51(4): 851-859.
|
[15]
|
穆杰, 纪文婷, 任北大, 连雅君, 杜欣, 王雪茜, 等. 肝气郁结在神经-代谢层面引起肝损伤的病理机制[J]. 中华中医药杂志, 2020, 35(3): 1194-1198.
|
[16]
|
李果. 交感神经经β肾上腺素能受体途径调控急性肝损伤的研究[D]: [硕士学位论文]. 第三军医大学, 2012.
|
[17]
|
钱令嘉. 应激生理学-生命维护和疾病控制的重要领域[J]. 生理科学进展, 2013, 44(5): 321-322
|
[18]
|
宦宏波, 夏锋, 吴林, 吴黎雳, 邓翔, 马宽生, 等. 肝脏去交感神经状态对大鼠脂类和激素代谢的影响[J]. 实用临床医药杂志, 2014, 18(9): 1-5.
|
[19]
|
Lei, H.Y., Ding, Y.H., Nie, K., et al. (2021) Poten-tial Effects of SARS-CoV-2 on the Gastrointestinal Tract and Liver. Biomedicine & Pharmacotherapy, 133, Article ID: 111064. https://doi.org/10.1016/j.biopha.2020.111064
|
[20]
|
Sharma, L. and Riva, A. (2020) Intestinal Barrier Func-tion in Health and Disease—Any Role of Sars-Cov-2? Microorganisms, 8, Article No. 1744. https://doi.org/10.3390/microorganisms8111744
|
[21]
|
Ghosh, S.S., Wang, J., Yannie, P.J., et al. (2020) Intestinal Barrier Function and Metabolic/Liver Diseases. Liver Research, 4, 81-87. https://doi.org/10.1016/j.livres.2020.03.002
|
[22]
|
刘颖, 王凯, 纪晓霞, 等. 肾素血管紧张素系统(RAS)两条轴相互负向调节与大鼠非酒精性脂肪肝病(NAFLD)肝损伤的关系研究[J]. 畜牧与兽医, 2019, 51(5): 48-54.
|
[23]
|
Santos, R.A.S., Sampaio, W.O., Alzamora, A.C., et al. (2018) The ACE2/Angiotensin-(1-7)/Mas Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7). Physiological Reviews, 98, 505-553.
https://doi.org/10.1152/physrev.00023.2016
|
[24]
|
Tsutsumi, T., Saito, M., Nagai, H., et al. (2021) Association of Coagulopathy with Liver Dysfunction in Patients with COVID‐19. Hepatology Research, 51, 227-232. https://doi.org/10.1111/hepr.13577
|
[25]
|
Amitrano, L., Guardascione, M.A., Brancaccio, V., et al. (2002) Coagula-tion Disorders in Liver Disease. Seminars in Liver Disease, 22, 83-96. https://doi.org/10.1055/s-2002-23205
|
[26]
|
Mammen, E.F. (1994) Coagulation Defects in Liver Disease. Medical Clinics of North America, 78, 545-554.
https://doi.org/10.1016/S0025-7125(16)30146-8
|
[27]
|
Chen, S., Liu, H., Li, T., et al. (2020) Correlation Analysis of Coagulation Dysfunction and Liver Damage in Patients with Novel Coronavirus Pneumonia: A Single-Center, Retro-spective, Observational Study. Upsala Journal of Medical Sciences, 125, 293-296. https://doi.org/10.1080/03009734.2020.1822960
|
[28]
|
姜慧, 齐向华, 滕晶. 吴又可《瘟疫论》理论辨析新型冠状病毒肺炎[J]. 四川中医, 2020, 38(3): 12-14.
|
[29]
|
姚荷生, 潘佛巖, 廖家兴. 脏象学说与诊断应用的文献探讨-脾脏、肝脏、肺脏[M]. 北京: 人民卫生电子音像出版社, 2014: 28.
|